Aeterna Zentaris Inc AEZS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:30 AM EDT
2.05quote price arrow down-0.04 (-1.91%)
Volume
2,519
52 week range
1.36 - 3.30
Loading...
  • Open2.14
  • Day High2.14
  • Day Low2.05
  • Prev Close2.09
  • 52 Week High3.30
  • 52 Week High Date05/08/23
  • 52 Week Low1.36
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap9.955M
  • Shares Out4.86M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change12.37

KEY STATS

  • Open2.14
  • Day High2.14
  • Day Low2.05
  • Prev Close2.09
  • 52 Week High3.30
  • 52 Week High Date05/08/23
  • 52 Week Low1.36
  • 52 Week Low Date11/01/23
  • Market Cap9.955M
  • Shares Out4.86M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change12.37

RATIOS/PROFITABILITY

  • EPS (TTM)-13.64
  • P/E (TTM)-0.15
  • Fwd P/E (NTM)-0.59
  • EBITDA (TTM)-17.839M
  • ROE (TTM)-61.34%
  • Revenue (TTM)4.498M
  • Gross Margin (TTM)95.06%
  • Net Margin (TTM)-368.01%
  • Debt To Equity (MRQ)1.53%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date05/03/2024
  • Split Factor4.0

Latest On Aeterna Zentaris Inc

 

Profile

MORE
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin...
Carolyn Egbert J.D., Ph.D.
Non-Executive Independent Chairman of the Board
Klaus Paulini Ph.D.
President, Chief Executive Officer, Director and Managing Director - AEZS Germany
Giuliano La Fratta
Chief Financial Officer, Senior Vice President
Address
315 Sigma Drive
Summerville, NB
29486
Canada

Top Peers

SYMBOLLASTCHG%CHG
AEZS
Aeterna Zentaris Inc
2.05-0.04-1.91%
ATE
RVX
Resverlogix Corp
0.06UNCHUNCH
KTRA
Kintara Therapeutics Inc
0.1451-0.0029-1.9595%
PRTG
Portage Biotech Inc
0.231+0.001+0.4348%